Alzheimer’s Benefits May Continue After Donanemab Treatment Ends, Data Suggest
(MedPage Today) — New data suggested that donanemab (Kisunla) sustained long-term benefits after a limited dosing period in a subgroup of people with early symptomatic Alzheimer’s disease.
Early Alzheimer’s patients who completed their course…
Share this Post
More Posts
Textbooks were wrong: Scientists reveal the surprising way human hair really grows
Hair may grow in a completely different way than scientists once believed. Instead of being pushed out from the root,
Scientists discover giant swirling plumes hidden deep inside Greenland’s ice sheet
Scientists may have finally solved the mystery of strange plume-like structures hidden deep inside the Greenland ice sheet. New research
Scientists discover ancient DNA “switches” hidden in plants for 400 million years
Scientists have uncovered an enormous hidden archive of plant DNA that has endured for more than 400 million years. By
Subscribe to our Newsletter
Executive Orders
Latest Posts
Environmental & Climate Health Sciences
Scientists warn Australia’s “zombie tree” could vanish within a generation
Health Policy & Health Systems Management
Cardiology Group to Pay Nearly $5 Million for Alleged Vein Ablation Fraud
Infectious Disease Control
U.S. Flu Season Winding Down
Health Policy & Health Systems Management
